Julius Berger Nigeria Plc (NGX:JBERGER)

Orchard Therapeutics Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	201,600	248,400	68,800	39,200	35,760	28,195
Market Cap Growth	14.29%	261.05%	75.51%	9.62%	26.83%	7.34%
Enterprise Value	146,307	124,470	-22,903	59,679	94,987	54,945
Last Close Price	126.00	151.57	40.50	21.24	17.70	13.67
PE Ratio	18.36	16.02	5.48	4.95	4.29	22.81
Forward PE	-	4.93	4.93	4.93	4.93	4.93
PS Ratio	0.30	0.44	0.16	0.09	0.11	0.12
PB Ratio	0.55	0.72	0.65	0.69	0.67	0.63
P/TBV Ratio	0.63	0.81	0.84	0.89	0.89	0.90
P/FCF Ratio	-	-	0.91	2.06	1.08	-
P/OCF Ratio	-	-	0.85	0.93	0.53	4.85
EV/Sales Ratio	0.22	0.22	-	0.14	0.28	0.23
EV/EBITDA Ratio	-	192.11	-	1.74	3.10	2.91
EV/EBIT Ratio	-	-	-	2.62	4.19	4.40
EV/FCF Ratio	-1.65	-	-	3.13	2.87	-
Debt / Equity Ratio	0.13	0.12	0.29	0.33	0.75	0.78
Debt / EBITDA Ratio	-	8.08	1.25	0.52	1.20	1.67
Debt / FCF Ratio	-	-	0.40	0.98	1.21	-
Asset Turnover	0.74	0.66	0.74	0.90	0.84	0.75
Inventory Turnover	6.86	6.39	7.15	9.20	10.30	10.73
Quick Ratio	3.03	3.55	3.16	2.65	2.59	1.80
Current Ratio	3.66	4.30	3.78	3.21	2.99	2.02
Return on Equity (ROE)	4.20%	6.86%	15.35%	14.37%	17.02%	2.90%
Return on Assets (ROA)	-1.20%	-0.66%	1.20%	2.89%	3.52%	2.43%
Return on Capital (ROIC)	-3.51%	-2.14%	6.73%	16.86%	16.40%	10.40%
Return on Capital Employed (ROCE)	-	-	2.00%	5.30%	5.90%	4.90%
Earnings Yield	5.44%	6.24%	18.25%	20.19%	23.33%	4.38%
FCF Yield	-43.87%	-21.57%	109.51%	48.61%	92.48%	-12.66%
Dividend Yield	2.58%	2.14%	7.41%	11.77%	14.12%	2.90%
Payout Ratio	48.52%	31.23%	31.87%	50.54%	7.59%	213.55%
Buyback Yield / Dilution	0.44%	-	-	-	1.00%	-
Total Shareholder Return	3.02%	2.14%	7.41%	11.77%	15.12%	2.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.